baber/WOPTO huggingface dataset:
Patent MX-2010012980-A (MX)
Title: Mixing assembly comprising a mixing chamber and an overflow chamber and process for mixing.
Inventor: SCORRANO LUCIO
IPC: B01F15/00
Filed: 2009-05-26
Abstract: The invention concerns a mixing assembly (1) comprising a mixing chamber (2) adapted to mix a soluble ingredient with a diluent, wherein the mixing assembly comprises an overflow channel (41), said overflow channel running along the external wall of the mixing chamber so that a liquid exceeding the capacity of the mixing chamber is able to flow in the overflow channel and the outlets (3) of the mixing chamber and the overflow channel allowing the liquid contained in the mixing chamber and the overflow channel to exit and mix in the same place. The invention also concerns a process for mixing a soluble ingredient with a diluent using the above mixing assembly.
Patent MX-2011000732-A (MX)
Title: Clutch-brake assembly.
Inventor: LATSKO JAMES M
IPC: F16D65/12
Filed: 2009-07-17
Abstract: A clutch-brake assembly transmits force to rotate a shaft and to retain the shaft against rotation. The assembly includes a plurality of force transmitting members (190) which transmit force between a piston and a base member. A plurality of springs (134) urge the piston to move relative to the base member. A plurality of spring retainers (180) are disposed between the base member and the piston. Each of the spring retainers includes a plurality of projecting portions extending from the base portion. The brake and clutch surface include friction material having a plurality of segments separated by a plurality of radially extending grooves.
Patent MX-2011000868-A (MX)
Title: Compositions for the treatment of pain and/or inflamation.
Inventor: SERRAIMA CRISTINA CARRENO
IPC: A61K38/17
Filed: 2009-07-24
Abstract: Compositions for the treatment of pain and/or inflammation comprising at least one peptide with the general formula (I) R1-AA-R2 , its stereoisomers, mixtures thereof, and its cosmetically and pharmaceutically acceptable salts. Peptide with general formula (I), its stereoisomers, mixtures thereof, and its cosmetically and pharmaceutically acceptable salts for the treatment of pain and/or inflammation.
Patent MX-2011003132-A (MX)
Title: Hafnia phytase variants.
Inventor: VIND JESPER
IPC: A23L7/104
Filed: 2009-09-28
Abstract: The present invention relates to phytases having at least 76% identity to a phytase derived from Hafnia alvei and comprises at least one modification in the amino acid sequence thereof. These phytase variants have modified, preferably improved, properties, such as, reduced protease sensitiliby, preferably they exhibit improved properties in respect of thermal performance, such as heat-stability (temperature stability, thermostability), steam stability, pelleting stability and/or temperature profile; and/or protease stability, in particular pepsin stability, pH profile, specific activity, substrate specificity, performance in animal feed(such as an improved release and/or degradation of phytate), susceptibility to glycation, and/or glycosylation pattern. The invention also relates to DNA encoding these phytases, methods of thei r production, as well as the use thereof, e.g. in animal feed and animal feed additives.
Patent MX-2011003833-A (MX)
Title: Highly concentrated drug particles, formulations, suspensions and uses thereof.
Inventor: ALESSI THOMAS R
IPC: A61K47/18
Filed: 2009-10-14
Abstract: Highly concentrated drug particle formulations are described, wherein the drug comprises between about 25 wt% and 80 wt% of the particle formulation. The particle formulations of the present invention comprise, for example, macromolecules, such as proteins and/or small molecules (such as steroid hormones). The particle formulation typically further includes one or more additional component, for example, one or more stabilizer (e.g., carbohydrates, antioxidants, amino acids, and buffers). Such concentrated particle formulations can be combined with a suspension vehicle to form suspension formulations. The suspension formulation comprises (i) a non-aqueous, single-phase vehicle, comprising one or more polymer and one or more one solvent, wherein the vehicle exhibits viscous fluid characteristics, and (ii) a highly concentrated drug particle formulation. Devices for delivering the suspension formulations and methods of use are also described. The present invention provides needed improvements in drug formulation and delivery to improve patient compliance and expand drug availability.
Patent MX-2011003860-A (MX)
Title: Fabric including polyurethane elastic yarn.
Inventor: HIETPAS GEOFFREY D
IPC: D03D15/56
Filed: 2009-10-09
Abstract: An article comprising a fabric wherein said fabric comprises a cationic dyeable polyurethane elastic yarn and an acid dyeable yarn.
Patent MX-2011005817-A (MX)
Title: Three-dimensional vertical hydration/dehydration sensor.
Inventor: SONG XUEDONG
IPC: A61F13/42
Filed: 2009-10-13
Abstract: A three-dimensional fluidic assay device or sensor is described. The sensor has a porous substrate with a first face or plane defined along x-y coordinate axes, and a second face remote in a z-direction from the first face. The first face contains a sample deposition zone and the second face has at least one detection zone, such that when a fluid sample is deposited in the sample deposition zone, fluid is transported by means of capillary action along the z-direction to the detection zone and manifests a signal development. An absorbent article, such as a diaper or feminine hygiene product, having such a three- dimensional sensor integrated across the thickness of the absorbent article, from an inner layer to an outer layer, is also described.
Patent MX-2011007869-A (MX)
Title: Method for ip address management in networks using a proxy based approach in mobile ip telephony.
Inventor: GANDHAM SHASHIDAR R
IPC: H04W36/00
Filed: 2010-01-20
Abstract: A system and method for a mobile switching center to efficiently manage; assign; and reclaim the IP addresses is described. The procedure utilizes a mechanism that involves splitting the IP address assignment functionality into two parts, with the Base Station being responsible for assigning IP addresses to individual end user devices and the mobile switching center assigning a block of IP addresses to each Base Station and includes a methodology for the mobile switching center to efficiently manage; assign and reclaim the IP addresses.
Patent MX-2011009048-A (MX)
Title: Method for determining uncertainty with projected wellbore position and attitude.
Inventor: ZAMANIAN S AHMAD
IPC: E21B44/00
Filed: 2011-08-29
Abstract: A system and method for determining uncertainty of a wellbore orientation is disclosed. The system and method obtains a measurement related to a first orientation of a drill string at a measurement device. Based on the first orientation and drilling settings, the system and method predict a second orientation. A probability of the second orientation being within a predetermined area is also obtained. As a result of this information, an action may be taken, such as, skipping a planned static survey, obtaining a static survey prior to the plan, or changing a drilling setting.
Patent MX-2011009274-A (MX)
Title: Welding helmet audio communication systems and methods with bone conduction transducers.
Inventor: BECKER WILLIAM JOSHUA
IPC: A61F9/06
Filed: 2010-01-28
Abstract: A system for welding communication that includes a welding headgear and a bone conduction transducer (BCT) disposed in or on the welding headgear is provided. The BCT facilitates communication of signals to a welding operator via bone conduction. The bone conduction facilitates the transmission of sound directly to an inner ear of the welding operator.
Patent MX-2011010003-A (MX)
Title: Guide nozzle for use with filter rod manufacturing apparatus.
Inventor: LEWIS WILLIAM DAVID
IPC: A24D3/02
Filed: 2010-02-23
Abstract: A guide nozzle (112) for use with an apparatus (110) for the manufacture of filter rods for smoking articles. The guide nozzle comprises a support member (130) configured to be fixed relative to said apparatus for the manufacture of filter rods, a funnel (120) through which loose filter material is propelled, mounted to the support member and, an adjuster (140) mounted between the support member and the funnel to enable the relative position of the funnel and the support member to be adjusted to control the direction of flow of loose filter material propelled through the funnel. An apparatus for the manufacture of filter rods for smoking articles having such a guide nozzle, and a method of manufacturing a filter rod using the same.
Patent MX-2011012661-A (MX)
Title: Method for eliminating spikes of mercury emissions.
Inventor: JEPSEN OVE
IPC: B01D53/10
Filed: 2010-05-28
Abstract: A method for the reduction of mercury emissions from an industrial plant that utilizes a cement or minerals kiln that has a high level of mercury emissions during specific operating conditions. The invention reduces a large spike in mercury emissions typically seen in cement kiln systems when the in-line raw mill is shut-down and all preheater gases are vented to the stack directly. The invention diverts the preheater gases to a cooling device that functions as an adsorption reactor to provide mercury absorption during periods when the raw mill is not in operation.
Patent MX-2012000029-A (MX)
Title: Compositions for treating degenerative joint diseases.
Inventor: OESSER STEFFEN
IPC: A23L1/00
Filed: 2010-06-18
Abstract: The invention relates to a composition for treating degenerative joint diseases having improved effectivity, wherein the composition comprises collagen hydrolysate and rosehip powder and/or extract, wherein the weight ratio of collagen hydrolysate to rosehip powder and/or extract, based on dry weight, is in the range from approximately 2:1 to approximately 100:1.
Patent MX-2012004971-A (MX)
Title: Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin.
Inventor: STERN JERRY O
IPC: A61K38/21
Filed: 2010-10-27
Abstract: The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin and particular regimens for administering this combination. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
Patent MX-2012005815-A (MX)
Title: Method for treating retinal conditions using an intraocular tamponade.
Inventor: LALLEMAND FREDERIC
IPC: A61K47/14
Filed: 2010-11-19
Abstract: Composition comprising at least one fatty acid glycerol ester for use during or after a vitrectomy procedure, said composition being bioresorbable, being injectable in the vitreous cavity, having a density below 1, more preferably comprised between 0.90 and 1, or a density above 1 more preferably between 1 and 1.5; having a surface tension of less than 50 dynes/cm more preferably ranging from 20 and 30 dynes/cm, being not susceptible to emulsify into droplets when injected; method for treating a retinal disorder involving the use of said composition.
Patent MX-2012006106-A (MX)
Title: Pharmaceutical compositions comprising sigma receptor ligands.
Inventor: RANZANI LUIS SOLER
IPC: A61K9/16
Filed: 2010-11-25
Abstract: The present invention relates to a pharmaceutical composition that comprises a compound of formula (I) as active pharmaceutical ingredient: or a pharmaceutically acceptable salt, isomer, prodrug or solvate thereof; and at least a pharmaceutically acceptable excipient, wherein the active pharmaceutical ingredient is present in an amount of at least 80% of the total dry weight of the composition.
Patent MX-2012007615-A (MX)
Title: Cooperating receiver selection for umts wireless location.
Inventor: MIA RASHIDUS S
IPC: G01S5/14
Filed: 2010-12-20
Abstract: For Wireless Communications Networks (WCNs) that support soft handover, cooperator receiver selection for a TDOA, AOA, TDOA/AOA, or hybrid network-based or network-overlay Wireless Location System (WLS) must contend with one or more network base stations as a serving cell. When the active set contains more than one member, two techniques for determining a set of cooperating and demodulating receivers to use in the signal collection for location estimation is disclosed. In one embodiment, the active set members are constructively reduced to a single member that is used as a proxy serving cell. In another embodiment, the information contained in the active set membership is retained and a new set of demodulating and cooperator receivers are generated based on the entire membership of the active set. For Wireless Communications Networks (WCNs) that support soft handover, cooperator receiver selection for a TDOA, AOA, TDOA/AOA, or hybrid network-based or network-overlay Wireless Location System (WLS) must contend with one or more network base stations as a serving cell. When the active set contains more than one member, two techniques for determining a set of cooperating and demodulating receivers to use in the signal collection for location estimation is disclosed. In one embodiment, the active set members are constructively reduced to a single member that is used as a proxy serving cell. In another embodiment, the information contained in the active set membership is retained and a new set of demodulating and cooperator receivers are generated based on the entire membership of the active set. A method comprises a providing a carbohydrate; reacting the carbohydrate directly with hydrogen in the presence of a hydrogenolysis catalyst to produce a reaction product comprising a polyol; and then processing at least a portion of the reaction product to form a fuel blend.
Patent MX-2012012132-A (MX)
Title: Novel highly-specified polyvalent immunotherapeutic drugs based on modified antibodies and highly-secure and effective injectable lyophilized formulation.
Inventor: PEREZ JUAN LOPEZ DE SILANES
IPC: A61K39/00
Filed: 2012-10-18
Abstract: The present invention is related to the production and development of an injectable lyophilized formulation of modified antibodies or variants thereof, which are highly specific neutralizers of heterologous mixtures of proteins, peptides and further organic and inorganic components which have different specific activities and may include but not limited to venoms for poisonous animals. The invention may refer to venoms, but includes all type of venoms for land and marine animals. The invention also refers to a production method that includes mammal hyper-immunization for producing highly-specific antibodies, the modification (fragmentation) and purification process, and finally the lyophilized injectable formulation, which provides the same with high-purity and -specificity properties.
Patent MX-2012014868-A (MX)
Title: Led lighting assembly and method of lighting for a merchandise display.
Inventor: SWAFFORD JOHN WESLEY JR
IPC: A47F3/00
Filed: 2011-06-17
Abstract: Aspects of the disclosure relate to a lighting assembly and method for illuminating a vertical planar area, such as a merchandise display. The lighting assembly can comprise two opposing support arms and a lighting bar extending between the two opposing support arms, a circuit board having a plurality of LEDs mounted to the inside of the lighting bar; and a plurality of lenses placed over a corresponding one of the plurality of LEDs. The lens may be positioned around every other LED on the lighting bar to capture light from a respective LED, modify the beam pattern, and re-project the light such that the light emitted from the lighting assembly is distributed substantially evenly in a vertical plane or direction.
Patent MX-2013000997-A (MX)
Title: 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds.
Inventor: BANNER DAVID
IPC: C07D239/22
Filed: 2011-08-05
Abstract: This invention relates to compounds of the formula wherein R1 to R9 are as described below, or to pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the therapeutic and/or prophylactic treatment of diseases such as diabetes, particularly type 2 diabetes, and other metabolic disorders.
Patent MX-2013001878-A (MX)
Title: Simultaneous anoxic biological phosphorus and nitrogen removal with energy recovery.
Inventor: GIRALDO EUGENIO
IPC: C02F3/30
Filed: 2011-09-08
Abstract: Methods and systems are provided for treating wastewater to simultaneously remove nitrogen, carbon, and phosphorus, while recovering energy in the form of methane and carbon dioxide. An ammonia-containing stream is directed to a pretreatment tank that produces excess sludge, biogas, and a pretreated stream. The pretreated stream has at least 45% less carbon than the ammonia-containing stream. The pretreated stream is then directed to an anoxic tank, which promotes phosphorus release and fermentation of particulate and dissolved organic matter. The mixed liquor is transferred to an aerated tank having low dissolved oxygen concentrations to promote development of phosphorus-release bacteria that is eventually recycled to the anoxic tank by way of the return activated sludge. Simultaneous nitrification, denitrification, and phosphorus release occur in the aerated tank. A membrane tank separates treated effluent from activated sludge in a membrane tank.
Patent MX-2013005300-A (MX)
Title: Leave-on non-solid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid.
Inventor: MELDRUM HELEN
IPC: A61K8/365
Filed: 2011-10-21
Abstract: Leave-on non-solid skin conditioning compositions containing 12-[(12- hydroxyoctadecanoyl)oxy] octadecanoic acid. 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid can be easily incorporated in combination with lipophilic carriers that are liquid at room temperature. Compositions are able to deliver increased energy production by human fibroblasts. Preferred compositions also contain 12-hydroxystearic acid and thus are able to deliver a wide range of skin benefits.
Patent MX-2013005377-A (MX)
Title: Alumina catalyst support.
Inventor: POLLI ANDREW
IPC: B01J21/12
Filed: 2011-11-16
Abstract: The present invention is directed to a high surface area, high pore volume porous alumina, comprising: aluminum oxide, optionally, silicon oxide and aluminosilicates, and optionally one or more dopants, said alumina having a specific surface area of from about 100 to about 500 square meters per gram and a total pore volume after calcination at 900Â°C for 2 hours of greater than or equal to 1.2 cubic centimeters per gram, wherein less than or equal to 15% of the total pore volume is contributed by pores having a diameter of less than 10 nm.
Patent MX-2013008422-A (MX)
Title: Therapeutic agent for alopecia.
Inventor: ENDO KYOKO
IPC: A61K45/00
Filed: 2012-01-20
Abstract: The present invention addresses the problem of providing a novel therapeutic agent for alopecia which: is safe and effective against alopecia, particularly alopecia areata, male pattern baldness in men, male pattern baldness in women, female pattern baldness, postpartum alopecia, seborrheic alopecia, alopecia pityrodes, alopecia senilis, alopecia due to chemotherapeutic agents, and alopecia due to radiation exposure; is also effective for subjects who are resistant to minoxidil and finasteride treatments; and is free of side effects such as itching, irritation and feminization, has no contraindications, reduces dandruff, has a therapeutic effect on grey hair, and has no long-term loss in therapeutic effect on alopecia even when stopped. The means for solving this problem is a therapeutic agent for alopecia that uses a C-type natriuretic peptide (CNP) or a B-type natriuretic peptide (BNP), derivatives of these natriuretic peptides (NPs), chimeric peptides of these NPs or derivatives of these NPs as active ingredients.
Patent MX-2013014240-A (MX)
Title: [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid.
Inventor: FREDDO JAMES L
IPC: A61K31/5415
Filed: 2012-06-06
Abstract: The present invention describes [1,2,4]thiadiazine 1,1-dioxide compounds and pharmaceutically acceptable salts thereof, which are useful in lowering serum uric acid in a patient in need thereof comprising administering to the patient a therapeutically or prophylactically effective amount of a [1,2,4]thiadiazine 1,1- dioxide compound.
Patent MX-2014000520-A (MX)
Title: Method for the production of castings for electrical applications.
Inventor: BAUER STEFFEN
IPC: C21D11/00
Filed: 2014-01-13
Abstract: The method comprises melting and filling a hardenable aluminum alloy into a die casting mold (4), and cooling the melted aluminum alloy (1) by the mold made of a material having a thermal conductivity causing the melted aluminum alloy to be cooled at a cooling rate >= 5x 10 2> K/s, where the melted aluminum alloy is introduced into a filling chamber (2) and is displaced at a minimal displacement speed within the filling chamber, prior to the filling step. The molten alloy is displaced at a low speed of less than 0.5 m/s in a filling chamber in the first phase. The method comprises melting and filling a hardenable aluminum alloy into a die casting mold (4), and cooling the melted aluminum alloy (1) by the mold made of a material having a thermal conductivity causing the melted aluminum alloy to be cooled at a cooling rate >= 5x 10 2> K/s, where the melted aluminum alloy is introduced into a filling chamber (2) and is displaced at a minimal displacement speed within the filling chamber, prior to the filling step. The molten alloy is displaced at a low speed of less than 0.5 m/s in a filling chamber in the first phase. The molten alloy is moved at high speed of 1-3 m/s from the filling chamber into the die-casting mold in a second phase. The molten alloy is set after complete filling of the die under pressure.
Patent MX-2014002634-A (MX)
Title: Coating system.
Inventor: KRÜSEMANN JULIANE
IPC: C09D7/41
Filed: 2012-09-14
Abstract: A coating formed on a substrate is provided which coating comprises (a) an organic NIR-transparent pigment and/or an inorganic NIR-reflective pigment; (b) a dye having a transmittance of at least 75% in the range of from 700 to 2500 nm; and (c) optionally an effect pigment; wherein said coating exhibits a total solar reflectance (TSR) of (i) â¥ 40%, if 60 < L* < 100, or (ii) â¥ 30%, if 30 < L* â¤ 60, or (iii) â¥ 20%, if 0 < L* â¤ 30, wherein L* is the lightness. The coating is suitable for an exterior-use coating like an industrial coating or a coating for vehicles, especially an automotive finish, having improved jetness.
Patent MX-2014003513-A (MX)
Title: Surgical staple assembly with hemostatic feature.
Inventor: WANG YI-LAN
IPC: A61B17/072
Filed: 2012-09-19
Abstract: A surgical instrument includes a handle portion, a shaft housing a firing bar, an end effector comprising an anvil, a lower jaw, and a stapling and severing assembly responsive to a longitudinal closing motion produced by the handle portion and the shaft. The lower jaw is configured to receive a removable cartridge. The cartridge includes a housing, a plurality of staples disposed in the housing, a deck disposed over the plurality of staples, and a fastener insert tip including a plurality of hooks. The deck defines apertures, with each aperture being substantially disposed over each staple. The instrument includes a fastener insert including hooks, and the fastener insert is removably received in the anvil. A buttress is attached to one or both of the anvil and the cartridge via the hooks.
Patent MX-2014004245-A (MX)
Title: Substituted tetrahydroisoquinoline compounds as factor xia inhibitors.
Inventor: ORWAT MICHAEL J
IPC: C07D401/14
Filed: 2012-10-12
Abstract: The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.